Related Experiment Videos
Molecular-clinical correlative studies in non-small cell lung cancer: application of a three-tiered approach
D R Gandara1, P N Lara, D H Lau
1Cancer and Molecular Research Laboratory, University of California Davis Cancer Center, 4501 X Street, Sacramento, CA 95817, USA. david.gandara@ucdmc.ucdavis.edu
Lung Cancer (Amsterdam, Netherlands)
|December 13, 2001
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Efficacy of chemotherapy and atezolizumab in patients with non-small-cell lung cancer receiving antibiotics and proton pump inhibitors: pooled post hoc analyses of the OAK and POPLAR trials.
Annals of oncology : official journal of the European Society for Medical Oncology·2020
Bone turnover biomarkers identify unique prognostic risk groups in men with castration resistant prostate cancer and skeletal metastases: Results from SWOG S0421.
Cancer treatment and research communications·2019
Long-term survival in patients with advanced non-small-cell lung cancer treated with atezolizumab versus docetaxel: Results from the randomised phase III OAK study.
European journal of cancer (Oxford, England : 1990)·2018
A randomized phase 2 study of MK-2206 versus everolimus in refractory renal cell carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
A randomised phase II trial of selumetinib vs selumetinib plus temsirolimus for soft-tissue sarcomas.
British journal of cancer·2015
Innovative Clinical Trials: The LUNG-MAP Study.
Clinical pharmacology and therapeutics·2015
Long-term efficacy and adherence of a lung cancer screening strategy with extended LDCT intervals: Results from the BioMILD trial.
Lung cancer (Amsterdam, Netherlands)·2026
Robotic-assisted bronchoscopic biopsy and EBUS-TBNA in lung cancer: An outcome comparison between clinical and pathological staging.
Lung cancer (Amsterdam, Netherlands)·2026
Outcomes of long-term responders to immunotherapy in the treatment of advanced non-small cell lung cancer (NSCLC). A retrospective regional study.
Lung cancer (Amsterdam, Netherlands)·2026
First-line camrelizumab plus chemotherapy followed by camrelizumab-apatinib maintenance for ES-SCLC: a single-arm phase II study.
Lung cancer (Amsterdam, Netherlands)·2026
Standard targeted therapy implementation for driver alterations newly identified by comprehensive genomic profiling in clinically driver-negative advanced NSCLC.
Lung cancer (Amsterdam, Netherlands)·2026
Discordance in pleural mesothelioma response classification and modelling of impact on clinical trials.
Lung cancer (Amsterdam, Netherlands)·2026
Parameters predicting mortality in antifibrotic-treated IPF patients: mMRC, CPI, TLCO, FVC, GAP.
Biomarkers in medicine·2026
Contrast-Enhanced Ultrasound Evaluation of Papillary Renal Cell Carcinoma.
Ultrasound quarterly·2026
Ruling Out Early Distant Recurrence in Stage III Colon Cancer: A Simple 4-Variable Machine Learning Model with External Validation.
Diseases of the colon and rectum·2026
ASSOCIATION OF TUMOR DEPOSITS WITH TUMOR PATHOLOGY AND SURVIVAL IN GASTRIC CANCER: A CROSS-SECTIONAL STUDY.
Arquivos de gastroenterologia·2026